Filing Flows › Fulgent Genetics (FLGT) › How it makes money
How Fulgent Genetics (FLGT) makes money
Fulgent Genetics (FLGT) made $90.4M of revenue in the third quarter 2026 (Q3 2026), +8% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $90.4M | 100.0% |
| Operating cash flow | $109M | 120.8% |
| Free cash flow | $107M | 118.8% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $90.4M | +8% |
| Q2 2026 | $85.4M | +4% |
| Q1 2026 | $71.1M | -3% |
| Q4 2025 | $83.3M | +9% |
| Q3 2025 | $84.1M | +17% |
| Q2 2025 | $81.8M | +15% |
| Q1 2025 | $73.5M | +14% |
From Fulgent Genetics' 10-Q filed Nov 5, 2026 (on EDGAR).
Questions
How does Fulgent Genetics make money?
Fulgent Genetics (FLGT) made $90.4M of revenue in the third quarter 2026 (Q3 2026), +8% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.